September, 2012 Monitor Topic Index

Monthly Topics Comments (0)

In the What We Learned section…Russia’s overly weighted grey market impacts health sector; Sanctions impact Iran’s pharma sector, and more.

In China Carlyle takes a long view on chronic illness; India rattles old pharma’s pricing scheme.

Bahrain looks to KSA as a healthcare model, in more ways than one. South Africa’s Mediclinic (MDC: J’burg) wants to go it alone in the UAE.

In Poland the famed Lux Med Company is for sale and we wonder if it’s the end of Lux Med as we know it. We see Carlyle again, this time in Turkey.

In Africa, Africa Medical Investments (AMEI: London) is beginning to turn itself around, shedding losses but borrowing more.

» Monthly Topics » September, 2012 Monitor Topic Index
On September 25, 2012

Leave a Reply

Your email address will not be published. Required fields are marked *

« »